The SGLT2i helps reduce hyperglycemia by increasing the urinary glucose excretion independent of insulin secretion or action, and the DPP4i inhibits the breakdown of active incretin hormones, improving glucose homeostasis by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner [11]. The gene discussed is INS; the disease is Hyperglycemia.